Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes

Chromatin modifications and their function

Kouzarides, T. (2007) · Cell · doi:10.1016/j.cell.2007.02.005 · Cited by 10,883 · see citing works

Lysine acetylation targets protein complexes and co-regulates major cellular functions

Choudhary, C., Kumar, C., Gnad, F., Nielsen, M. L., Rehman, M., Walther, T. C., Olsen, J. V., & Mann, M. (2009) · Science · doi:10.1126/science.1175371 · Cited by 4,040 · see citing works

Anticancer activities of histone deacetylase inhibitors

Bolden, J. E., Peart, M. J., & Johnstone, R. W. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2133 · Cited by 2,919 · see citing works

Proteome survey reveals modularity of the yeast cell machinery

Gavin, A., Aloy, P., Grandi, P., Krause, R., Böesche, M., Marzioch, M., Rau, C., Jensen, L. J., Bastuck, S., Dümpelfeld, B., et al. (2006) · Nature · doi:10.1038/nature04532 · Cited by 2,544 · see citing works

Pvclust: an R package for assessing the uncertainty in hierarchical clustering

Suzuki, R., & Shimodaira, H. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btl117 · Cited by 2,456 · see citing works

Regulation of cellular metabolism by protein lysine acetylation

Zhao, S., Xu, W., Jiang, W., Yu, W., Lin, Y., Zhang, T., Yao, J., Zhou, L., Zeng, Y., Li, H., et al. (2010) · Science · doi:10.1126/science.1179689 · Cited by 1,910 · see citing works

A Mammalian Histone Deacetylase Related to the Yeast Transcriptional Regulator Rpd3p

Taunton, J., Hassig, C. A., & Schreiber, S. L. (1996) · Science · doi:10.1126/science.272.5260.408 · Cited by 1,829 · see citing works

Parts per Million Mass Accuracy on an Orbitrap Mass Spectrometer via Lock Mass Injection into a C-trap

Olsen, J. V., de Godoy, L. M. F., Li, G., Maček, B., Mortensen, P., Pesch, R., Makarov, A., Lange, O., Horning, S. R., & Mann, M. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.t500030-mcp200 · Cited by 1,513 · see citing works

Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis

Gregoretti, I., Lee, Y.-M., & Goodson, H. V. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.02.006 · Cited by 1,456 · see citing works

The Cell as a Collection of Protein Machines: Preparing the Next Generation of Molecular Biologists

Alberts, B. (1998) · Cell · doi:10.1016/s0092-8674(00)80922-8 · Cited by 1,411 · see citing works

Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes

Wang, Z., Zang, C., Cui, K., Schones, D. E., Barski, A., Peng, W., & Zhao, K. (2009) · Cell · doi:10.1016/j.cell.2009.06.049 · Cited by 1,344 · see citing works

The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men

Yang, X., & Seto, E. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2346 · Cited by 1,239 · see citing works

Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug

Marks, P. A., & Breslow, R. (2007) · Nature Biotechnology · doi:10.1038/nbt1272 · Cited by 1,198 · see citing works

Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation

Zhang, Y., Ng, H.-H., Erdjument-Bromage, H., Tempst, P., Bird, A., & Reinberg, D. (1999) · Genes & Development · doi:10.1101/gad.13.15.1924 · Cited by 1,103 · see citing works

Extraction, purification and analysis of histones

Shechter, D., Dormann, H. L., Allis, C. D., & Hake, S. B. (2007) · Nature Protocols · doi:10.1038/nprot.2007.202 · Cited by 1,054 · see citing works

Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors

Bantscheff, M., Eberhard, D., Abraham, Y., Bastuck, S., Böesche, M., Hobson, S., Mathieson, T., Perrin, J., Raida, M., Rau, C., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1328 · Cited by 1,036 · see citing works

Chemical phylogenetics of histone deacetylases

Bradner, J. E., West, N., Grachan, M. L., Greenberg, E. F., Haggarty, S. J., Warnow, T., & Mazitschek, R. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.313 · Cited by 720 · see citing works

Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors

Khan, N., Jeffers, M., Kumar, S., Hackett, C., Boldog, F., Khramtsov, N., Qian, X., Mills, E., Berghs, S. C., Carey, N., et al. (2008) · Biochemical Journal · doi:10.1042/bj20070779 · Cited by 713 · see citing works

Chromatin deacetylation by an ATP-dependent nucleosome remodelling complex

Tong, J. K., Hassig, C. A., Schnitzler, G. R., Kingston, R. E., & Schreiber, S. L. (1998) · Nature · doi:10.1038/27699 · Cited by 692 · see citing works

The SMRT and N-CoR Corepressors Are Activating Cofactors for Histone Deacetylase 3

Guenther, M. G., Barak, O., & Lazar, M. A. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.18.6091-6101.2001 · Cited by 611 · see citing works

Histone Deacetylases and SAP18, a Novel Polypeptide, Are Components of a Human Sin3 Complex

Zhang, Y., Iratni, R., Erdjument-Bromage, H., Tempst, P., & Reinberg, D. (1997) · Cell · doi:10.1016/s0092-8674(00)80216-0 · Cited by 578 · see citing works

Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases

Lahm, A., Paolini, C., Pallaoro, M., Nardi, M. C., Jones, P., Neddermann, P., Sambucini, S., Bottomley, M. J., Lo Surdo, P., Carfı́, A., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706487104 · Cited by 566 · see citing works

CoREST is an integral component of the CoREST- human histone deacetylase complex

You, A., Tong, J. K., Grozinger, C. M., & Schreiber, S. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1454 · Cited by 500 · see citing works

A novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas

Balasubramanian, S., Ramos, J., Luo, W., Sirisawad, M., Verner, E., & Buggy, J. J. (2008) · Leukemia · doi:10.1038/leu.2008.9 · Cited by 458 · see citing works

HDAC6, at the crossroads between cytoskeleton and cell signaling by acetylation and ubiquitination

Boyault, C., Sadoul, K., Pabion, M., & Khochbin, S. (2007) · Oncogene · doi:10.1038/sj.onc.1210614 · Cited by 397 · see citing works

Identifying the proteins to which small-molecule probes and drugs bind in cells

Ong, S., Schenone, M., Margolin, A. A., Li, X., Do, K., Doud, M. K., Mani, D. R., Kuai, L., Wang, X., Wood, J. L., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900191106 · Cited by 304 · see citing works

Proteomics of the Eukaryotic Transcription Machinery: Identification of Proteins Associated with Components of Yeast TFIID by Multidimensional Mass Spectrometry

Sanders, S. L., Jennings, J. L., Canutescu, A. A., Link, A. J., & Weil, P. A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.13.4723-4738.2002 · Cited by 301 · see citing works

Activity-based probes for proteomic profiling of histone deacetylase complexes

Salisbury, C. M., & Cravatt, B. F. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608659104 · Cited by 243 · see citing works

Robust and Sensitive iTRAQ Quantification on an LTQ Orbitrap Mass Spectrometer

Bantscheff, M., Böesche, M., Eberhard, D., Mathieson, T., Sweetman, G. M. A., & Küster, B. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800029-mcp200 · Cited by 235 · see citing works

Pimelic Diphenylamide 106 Is a Slow, Tight-binding Inhibitor of Class I Histone Deacetylases

Chou, C. J., Herman, D., & Gottesfeld, J. M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m807045200 · Cited by 223 · see citing works

HDAC3: taking the SMRT-N-CoRrect road to repression

Karagianni, P., & Wong, J. (2007) · Oncogene · doi:10.1038/sj.onc.1210612 · Cited by 221 · see citing works

Regulation of Global Acetylation in Mitosis through Loss of Histone Acetyltransferases and Deacetylases from Chromatin

Kruhlak, M. J., Hendzel, M. J., Fischle, W., Bertos, N., Hameed, S., Yang, X., Verdin, E. M., & Bazett‐Jones, D. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100290200 · Cited by 207 · see citing works

Distinct pharmacological properties of second generation HDAC inhibitors with the benzamide or hydroxamate head group

Beckers, T. L., Burkhardt, C., Wieland, H., Gimmnich, P., Ciossek, T., Maier, T. M., & Sanders, K. (2007) · International Journal of Cancer · doi:10.1002/ijc.22751 · Cited by 191 · see citing works

High Precision Quantitative Proteomics Using iTRAQ on an LTQ Orbitrap: A New Mass Spectrometric Method Combining the Benefits of All

Köcher, T., Pichler, P., Schutzbier, M., Stingl, C., Kaul, A., Teucher, N., Hasenfuss, G. P., Penninger, J. M., & Mechtler, K. (2009) · Journal of Proteome Research · doi:10.1021/pr900451u · Cited by 152 · see citing works

Proteomics strategy for quantitative protein interaction profiling in cell extracts

Sharma, K., Weber, C. K., Bairlein, M., Greff, Z., Kéri, G., Cox, J., Olsen, J. V., & Daub, H. (2009) · Nature Methods · doi:10.1038/nmeth.1373 · Cited by 146 · see citing works

Revealing promiscuous drug–target interactions by chemical proteomics

Bantscheff, M., Scholten, A., & Heck, A. J. R. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.07.001 · Cited by 145 · see citing works

CDYL Bridges REST and Histone Methyltransferases for Gene Repression and Suppression of Cellular Transformation

Mulligan, P., Westbrook, T. F., Ottinger, M., Pavlova, N. N., Chang, B., Macia, E., Shi, Y.-J., Barretina, J. G., Liu, J., Howley, P. M., et al. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.10.025 · Cited by 143 · see citing works

Undesirable Charge-Enhancement of Isobaric Tagged Phosphopeptides Leads to Reduced Identification Efficiency

Thingholm, T. E., Palmisano, G., Kjeldsen, F., & Larsen, M. R. (2010) · Journal of Proteome Research · doi:10.1021/pr100230q · Cited by 121 · see citing works

Streamlined analysis schema for high-throughput identification of endogenous protein complexes

Malovannaya, A., Li, Y., Bulynko, Y. A., Jung, S. Y., Wang, Y., Lanz, R. B., O’Malley, B. W., & Qin, J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912599106 · Cited by 118 · see citing works

Probing the elusive catalytic activity of vertebrate class IIa histone deacetylases

JONES, P. G., Altamura, S., Francesco, R. D., Gallinari, P., Lahm, A., Neddermann, P., Rowley, M., Serafini, S., & Steinkühler, C. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.02.025 · Cited by 100 · see citing works

Eloquent silence: developmental functions of Class I histone deacetylases

Cunliffe, V. T. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.10.001 · Cited by 95 · see citing works

Targeted data acquisition for improved reproducibility and robustness of proteomic mass spectrometry assays

Savitski, M. M., Fischer, F. F., Mathieson, T., Sweetman, G. M. A., Lang, M., & Bantscheff, M. (2010) · Journal of the American Society for Mass Spectrometry · doi:10.1016/j.jasms.2010.01.012 · Cited by 88 · see citing works

Atrophin recruits HDAC1/2 and G9a to modify histone H3K9 and to determine cell fates

Wang, L., Charroux, B., Kerridge, S., & Tsai, C. (2008) · EMBO Reports · doi:10.1038/embor.2008.67 · Cited by 85 · see citing works

The use of diversity profiling to characterize chemical modulators of the histone deacetylases

Blackwell, L. J., Norris, J. L., Suto, C. M., & Janzen, W. P. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.03.004 · Cited by 78 · see citing works

Deacetylase Inhibitors Dissociate the Histone-Targeting ING2 Subunit from the Sin3 Complex

Smith, K. T., Martin‐Brown, S., Florens, L. A., Washburn, M. P., & Workman, J. L. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.12.010 · Cited by 75 · see citing works

Interference with Sin3 function induces epigenetic reprogramming and differentiation in breast cancer cells

Farias, E., Petrie, K. R., Leibovitch, B. A., Murtagh, J., Boix-Chornet, M., Schenk, T., Zelent, A., & Waxman, S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006737107 · Cited by 69 · see citing works

Switching on Epigenetic Therapy

Karberg, S. (2009) · Cell · doi:10.1016/j.cell.2009.11.038 · Cited by 47 · see citing works

H-Score, a Mass Accuracy Driven Rescoring Approach for Improved Peptide Identification in Modification Rich Samples

Savitski, M. M., Mathieson, T., Becher, I., & Bantscheff, M. (2010) · Journal of Proteome Research · doi:10.1021/pr1006813 · Cited by 35 · see citing works

Identification of functional domains in TdIF1 and its inhibitory mechanism for TdT activity

Kubota, T., Maezawa, S., Koiwai, K., Hayano, T., & Koiwai, O. (2007) · Genes to Cells · doi:10.1111/j.1365-2443.2007.01105.x · Cited by 19 · see citing works

Examinations of the antioxidative properties of the topically administered drug bufexamac reveal new insights into its mechanism of action

Trommer, H., Plätzer, M., Raith, K., Wohlrab, W., Podhaisky, H.-P., & Neubert, R. H. H. (2003) · Journal of Pharmacy and Pharmacology · doi:10.1211/002235703322461569 · Cited by 8 · see citing works

A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles

Subramanian, A., Narayan, R., Corsello, S. M., Peck, D. D., Natoli, T. E., Lu, X., Gould, J., Davis, J. F., Tubelli, A. A., Asiedu, J. K., et al. (2017) · Cell · doi:10.1016/j.cell.2017.10.049 · Cited by 3,515 · see citing works

Cancer epigenetics: from mechanism to therapy

Dawson, M. A., & Kouzarides, T. (2012) · Cell · doi:10.1016/j.cell.2012.06.013 · Cited by 3,203 · see citing works

Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders

Falkenberg, K. J., & Johnstone, R. W. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4360 · Cited by 1,564 · see citing works

Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia

Dawson, M. A., Prinjha, R. K., Dittmann, A., Giotopoulos, G., Bantscheff, M., Chan, W.-I., Robson, S. C., Chung, C., Hopf, C., Savitski, M. M., et al. (2011) · Nature · doi:10.1038/nature10509 · Cited by 1,512 · see citing works

New and emerging HDAC inhibitors for cancer treatment

West, A. C., & Johnstone, R. W. (2014) · Journal of Clinical Investigation · doi:10.1172/jci69738 · Cited by 1,404 · see citing works

Catalytic in vivo protein knockdown by small-molecule PROTACs

Bondeson, D. P., Mares, A., Smith, I. E. D., Ko, E., Campos, S., Miah, A. H., Mulholland, K. E., Routly, N., Buckley, D. L., Gustafson, J. L., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1858 · Cited by 1,356 · see citing works

Epigenetic protein families: a new frontier for drug discovery

Arrowsmith, C. H., Bountra, C., Fish, P. V., Lee, K., & Schapira, M. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3674 · Cited by 1,327 · see citing works

HDACs and HDAC Inhibitors in Cancer Development and TherapyPreprint

Li, Y., & Seto, E. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026831 · Cited by 1,309 · see citing works

Tracking cancer drugs in living cells by thermal profiling of the proteome

Savitski, M. M., Reinhard, F. B. M., Franken, H., Werner, T., Savitski, M. F., Eberhard, D., Molina, D. M., Jafari, R., Dovega, R. B., Klaeger, S., et al. (2014) · Science · doi:10.1126/science.1255784 · Cited by 1,187 · see citing works

A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response

Kruidenier, L., Chung, C.-W., Cheng, Z., Liddle, J., Che, K., Joberty, G., Bantscheff, M., Bountra, C., Bridges, A., Diallo, H., et al. (2012) · Nature · doi:10.1038/nature11262 · Cited by 950 · see citing works

Quantitative mass spectrometry in proteomics: critical review update from 2007 to the present

Bantscheff, M., Lemeer, S., Savitski, M. M., & Kuster, B. (2012) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-012-6203-4 · Cited by 801 · see citing works

Thermal proteome profiling for unbiased identification of direct and indirect drug targets using multiplexed quantitative mass spectrometry

Franken, H., Mathieson, T., Childs, D., Sweetman, G. M. A., Werner, T., Tögel, I., Doce, C., Gade, S., Bantscheff, M., Drewes, G., et al. (2015) · Nature Protocols · doi:10.1038/nprot.2015.101 · Cited by 663 · see citing works

Histone deacetylases as regulators of inflammation and immunity

Shakespear, M. R., Halili, M. A., Irvine, K. M., Fairlie, D. P., & Sweet, M. J. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.04.001 · Cited by 546 · see citing works

Cancer biology and NuRD: a multifaceted chromatin remodelling complex

Lai, A. Y., & Wade, P. A. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3091 · Cited by 541 · see citing works

Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitors

Delcuve, G. P., Khan, D. H., & Davie, J. R. (2012) · Clinical Epigenetics · doi:10.1186/1868-7083-4-5 · Cited by 505 · see citing works

Inherited and Somatic Defects in DDX41 in Myeloid Neoplasms

Polprasert, C., Schulze, I., Sekeres, M. A., Makishima, H., Przychodzen, B. P., Hosono, N., Singh, J., Padgett, R. A., Gu, X., Phillips, J. G., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.03.017 · Cited by 435 · see citing works

Histone Deacetylases (HDACs): Evolution, Specificity, Role in Transcriptional Complexes, and Pharmacological Actionability

Milazzo, G., Mercatelli, D., Muzio, G. D., Triboli, L., Rosa, P. D., Perini, G., & Giorgi, F. M. (2020) · Genes · doi:10.3390/genes11050556 · Cited by 431 · see citing works

Metabolic control of epigenetics in cancer

Kinnaird, A. S., Zhao, S., Wellen, K. E., & Michelakis, E. D. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.82 · Cited by 419 · see citing works

Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages

Chen, X., Barozzi, I., Termanini, A., Prosperini, E., Recchiuti, A., Dalli, J., Mietton, F., Matteoli, G., Hiebert, S., & Natoli, G. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121131109 · Cited by 397 · see citing works

Class I HDACs Share a Common Mechanism of Regulation by Inositol Phosphates

Millard, C. J., Watson, P. J., Celardo, I., Gordiyenko, Y., Cowley, S. M., Robinson, C. V., Fairall, L., & Schwabe, J. W. R. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.05.020 · Cited by 396 · see citing works

Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy

Wagner, J. M., Hackanson, B. W., Lübbert, M., & Jung, M. (2010) · Clinical Epigenetics · doi:10.1007/s13148-010-0012-4 · Cited by 391 · see citing works

Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group

Lobera, M., Madauss, K. P., Pohlhaus, D. T., Wright, Q. G., Trocha, M., Schmidt, D. R., Baloglu, E., Trump, R. P., Head, M. S., Hofmann, G. A., et al. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1223 · Cited by 384 · see citing works

B cell-intrinsic epigenetic modulation of antibody responses by dietary fiber-derived short-chain fatty acids

Sanchez, H. N., Moroney, J. B., Gan, H., Shen, T., Im, J. L., Li, T., Taylor, J. R., Zan, H., & Casali, P. (2020) · Nature Communications · doi:10.1038/s41467-019-13603-6 · Cited by 369 · see citing works

The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy

Guo, L., Tian, Y., & Zhu, W. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.576946 · Cited by 358 · see citing works

BLUEPRINT to decode the epigenetic signature written in blood

Adams, D., Altucci, L., Antonarakis, S., Ballesteros, J., Beck, S., Bird, A., Bock, C., Boehm, B., Campo, E., Caricasole, A., et al. (2012) · Nature Biotechnology · doi:10.1038/nbt.2153 · Cited by 374 · see citing works

The emerging role of mass spectrometry-based proteomics in drug discovery

Meissner, F., Geddes‐McAlister, J., Mann, M., & Bantscheff, M. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00409-3 · Cited by 355 · see citing works

ORY-1001, a Potent and Selective Covalent KDM1A Inhibitor, for the Treatment of Acute Leukemia

Maes, T., Mascaró, C., Tirapu, I., Estiarte, A., Ciceri, F., Lunardi, S., Guibourt, N., Perdones, A., Lufino, M. M., Somervaille, T. C. P., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.02.002 · Cited by 339 · see citing works

HDAC Inhibitors as Epigenetic Regulators of the Immune System: Impacts on Cancer Therapy and Inflammatory Diseases

Hull, E. E., Montgomery, M. R., & Leyva, K. J. (2016) · BioMed Research International · doi:10.1155/2016/8797206 · Cited by 316 · see citing works

Thermal proteome profiling monitors ligand interactions with cellular membrane proteins

Reinhard, F. B. M., Eberhard, D., Werner, T., Franken, H., Childs, D., Doce, C., Savitski, M. F., Huber, W. K., Bantscheff, M., Savitski, M. M., et al. (2015) · Nature Methods · doi:10.1038/nmeth.3652 · Cited by 310 · see citing works

HDAC inhibitor‐based therapies: Can we interpret the code?

New, M. I., Olzscha, H., & Thangue, N. B. L. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.09.003 · Cited by 310 · see citing works

The functional interactome landscape of the human histone deacetylase family

Joshi, P., Greco, T. M., Guise, A. J., Luo, Y., Yu, F., Nesvizhskii, A. I., & Cristea, I. M. (2013) · Molecular Systems Biology · doi:10.1038/msb.2013.26 · Cited by 289 · see citing works

Target engagement and drug residence time can be observed in living cells with BRET

Robers, M. B., Dart, M. L., Woodroofe, C. C., Zimprich, C., Kirkland, T. A., Machleidt, T., Kupcho, K. R., Levin, S., Hartnett, J. R., Zimmerman, K., et al. (2015) · Nature Communications · doi:10.1038/ncomms10091 · Cited by 275 · see citing works

HDAC8: a multifaceted target for therapeutic interventions

Chakrabarti, A., Oehme, I., Witt, O., Oliveira, G., Sippl, W., Romier, C., Pierce, R. J., & Jung, M. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.04.013 · Cited by 284 · see citing works

Measuring and Managing Ratio Compression for Accurate iTRAQ/TMT Quantification

Savitski, M. M., Mathieson, T., Zinn, N., Sweetman, G. M. A., Doce, C., Becher, I., Pachl, F., Küster, B., & Bantscheff, M. (2013) · Journal of Proteome Research · doi:10.1021/pr400098r · Cited by 278 · see citing works

Acetylation site specificities of lysine deacetylase inhibitors in human cells

Schölz, C., Weinert, B. T., Wagner, S., Beli, P., Miyake, Y., Qi, J., Jensen, L. J., Streicher, W. W., McCarthy, A. R., Westwood, N. J., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3130 · Cited by 271 · see citing works

Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase

Paquet, T., Manach, C. L., Cabrera, D. G., Younis, Y., Henrich, P. P., Abraham, T. S., Lee, M., Basak, R., Ghidelli, S., Lafuente-Monasterio, M. J., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aad9735 · Cited by 276 · see citing works

HDAC4 Governs a Transcriptional Program Essential for Synaptic Plasticity and Memory

Sando, R., Gounko, N., Pieraut, S., Liao, L., Yates, J., & Maximov, A. (2012) · Cell · doi:10.1016/j.cell.2012.09.037 · Cited by 274 · see citing works

Ion Coalescence of Neutron Encoded TMT 10-Plex Reporter Ions

Werner, T., Sweetman, G. M. A., Savitski, M. F., Mathieson, T., Bantscheff, M., & Savitski, M. M. (2014) · Analytical Chemistry · doi:10.1021/ac500140s · Cited by 250 · see citing works

Thermal profiling reveals phenylalanine hydroxylase as an off-target of panobinostat

Becher, I., Werner, T., Doce, C., Zaal, E. A., Tögel, I., Khan, C. A., Rueger, A., Muelbaier, M., Salzer, E., Berkers, C. R., et al. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2185 · Cited by 251 · see citing works

Determining target engagement in living systems

Simon, G. M., Niphakis, M. J., & Cravatt, B. F. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1211 · Cited by 246 · see citing works

Insights into the activation mechanism of class I HDAC complexes by inositol phosphates

Watson, P. J., Millard, C. J., Riley, A. M., Robertson, N. S., Wright, L. C., Godage, H. Y., Cowley, S. M., Jamieson, A. G., Potter, B. V. L., & Schwabe, J. W. R. (2016) · Nature Communications · doi:10.1038/ncomms11262 · Cited by 244 · see citing works

Potent and selective chemical probe of hypoxic signalling downstream of HIF-α hydroxylation via VHL inhibition

Frost, J., Galdeano, C., Soares, P., Gadd, M. S., Grzes, K. M., Ellis, L. C. J., Epemolu, O., Shimamura, S., Bantscheff, M., Grandi, P., et al. (2016) · Nature Communications · doi:10.1038/ncomms13312 · Cited by 242 · see citing works

Histone deacetylase 10 promotes autophagy-mediated cell survival

Oehme, I., Linke, J.-P., Böck, B. C., Milde, T., Lodrini, M., Hartenstein, B., Wiegand, I., Eckert, C., Roth, W., Kool, M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300113110 · Cited by 221 · see citing works

Analyzing Protein–Protein Interaction Networks

Koh, G. C. K. W., Porras, P., Aranda, B., Hermjakob, H., & Orchard, S. E. (2012) · Journal of Proteome Research · doi:10.1021/pr201211w · Cited by 209 · see citing works

Protein-protein interaction networks: probing disease mechanisms using model systems

Kuzmanov, U., & Emili, A. (2013) · Genome Medicine · doi:10.1186/gm441 · Cited by 197 · see citing works

Drug discovery considerations in the development of covalent inhibitors

Mah, R., Thomas, J. R., & Shafer, C. M. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.10.003 · Cited by 197 · see citing works

High-Resolution Enabled TMT 8-plexing

Werner, T., Becher, I., Sweetman, G. M. A., Doce, C., Savitski, M. M., & Bantscheff, M. (2012) · Analytical Chemistry · doi:10.1021/ac301553x · Cited by 189 · see citing works

How Chemoproteomics Can Enable Drug Discovery and Development

Moellering, R. E., & Cravatt, B. F. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.01.001 · Cited by 182 · see citing works

Targeting Class I Histone Deacetylases in a “Complex” Environment

Millard, C. J., Watson, P. J., Fairall, L., & Schwabe, J. W. R. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.12.006 · Cited by 180 · see citing works

New IDH1 mutant inhibitors for treatment of acute myeloid leukemia

Okoye-Okafor, U. C., Bartholdy, B., Cartier, J., Gao, E. N., Pietrak, B., Rendina, A. R., Rominger, C., Quinn, C., Smallwood, A., Wiggall, K. J., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1930 · Cited by 180 · see citing works

Genome-wide localization of small molecules

Anders, L., Guenther, M. G., Qi, J., Fan, Z. P., Marineau, J., Rahl, P. B., Lovén, J., Sigova, A. A., Smith, W. B., Lee, T. I., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2776 · Cited by 175 · see citing works

Mass Spectrometry-Based Proteomics in Preclinical Drug Discovery

Schirle, M., Bantscheff, M., & Küster, B. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.01.002 · Cited by 178 · see citing works

Identifying drug targets in tissues and whole blood with thermal-shift profiling

Perrin, J., Werner, T., Kurzawa, N., Rutkowska, A., Childs, D. D., Kalxdorf, M., Poeckel, D., Stonehouse, E., Strohmer, K., Heller, B., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-019-0388-4 · Cited by 178 · see citing works

Translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders

Ishoey, M., Chorn, S., Singh, N., Jaeger, M. G., Brand, M., Paulk, J., Bauer, S., Erb, M. A., Parapatics, K., Müller, A. C., et al. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.7b00969 · Cited by 177 · see citing works

Histone Deacetylase Inhibitors In The Treatment Of Cancer: Overview And Perspectives

Giannini, G., Cabri, W., Fattorusso, C., & Rodriquez, M. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.80 · Cited by 178 · see citing works

HDAC inhibitors attenuate the development of hypersensitivity in models of neuropathic pain

Denk, F., Huang, W. L., Sidders, B. S., Bithell, A., Crow, M., Grist, J., Sharma, S., Ziemek, D., Rice, A. S. C., Buckley, N. J., et al. (2013) · Pain · doi:10.1016/j.pain.2013.05.021 · Cited by 172 · see citing works

Identifying compound efficacy targets in phenotypic drug discovery

Schirle, M., & Jenkins, J. L. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.08.001 · Cited by 164 · see citing works

Discovery and Characterization of GSK2801, a Selective Chemical Probe for the Bromodomains BAZ2A and BAZ2B

Chen, P., Chaikuad, A., Bamborough, P., Bantscheff, M., Bountra, C., Chung, C., Fedorov, O., Grandi, P., Jung, D. K., Leśniak, R. K., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00209 · Cited by 165 · see citing works

Histone Deacetylases in Bone Development and Skeletal Disorders

Bradley, E. W., Shull, L. C., van Wijnen, A. J., McGee‐Lawrence, M. E., & Westendorf, J. J. (2015) · Physiological Reviews · doi:10.1152/physrev.00004.2015 · Cited by 163 · see citing works

Epigenetic drug discovery: breaking through the immune barrier

Tough, D. F., Tak, P. P., Tarakhovsky, A., & Prinjha, R. K. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.185 · Cited by 160 · see citing works

Chemoproteomics-Based Design of Potent LRRK2-Selective Lead Compounds That Attenuate Parkinson’s Disease-Related Toxicity in Human Neurons

Ramsden, N. G., Perrin, J., Ren, Z., Lee, B. D., Zinn, N., Dawson, V. L., Tam, D., Bova, M. P., Lang, M., Drewes, G., et al. (2011) · ACS Chemical Biology · doi:10.1021/cb2002413 · Cited by 154 · see citing works

Histone deacetylase 3 (HDAC 3) as emerging drug target in NF-κB-mediated inflammation

Leus, N. G. J., Zwinderman, M. R. H., & Dekker, F. J. (2016) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2016.06.019 · Cited by 152 · see citing works

Histone deacetylase inhibitors in hematological malignancies and solid tumors

Chun, P. (2015) · Archives of Pharmacal Research · doi:10.1007/s12272-015-0571-1 · Cited by 147 · see citing works

A selective inhibitor reveals PI3Kγ dependence of TH17 cell differentiation

Bergamini, G., Bell, K., Shimamura, S., Werner, T., Cansfield, A. D., Müller, K., Perrin, J., Rau, C., Ellard, K., Hopf, C., et al. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.957 · Cited by 147 · see citing works

Roles of Histone Deacetylases and Inhibitors in Anticancer Therapy

Verza, F. A., Das, U., Fachin, A. L., Dimmock, J. R., & Marins, M. (2020) · Cancers · doi:10.3390/cancers12061664 · Cited by 147 · see citing works

Histone deacetylase function in CD4+ T cells

Ellmeier, W., & Seiser, C. (2018) · Nature reviews. Immunology · doi:10.1038/s41577-018-0037-z · Cited by 144 · see citing works

Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis

Wyllie, S., Thomas, M. G., Patterson, S., Crouch, S., Rycker, M. D., Lowe, R., Gresham, S., Urbaniak, M. D., Otto, T. D., Stojanovski, L., et al. (2018) · Nature · doi:10.1038/s41586-018-0356-z · Cited by 146 · see citing works

Endogenous modulators and pharmacological inhibitors of histone deacetylases in cancer therapy

Spiegel, S., Milstien, S., & Grant, S. (2011) · Oncogene · doi:10.1038/onc.2011.267 · Cited by 141 · see citing works

Histone/protein deacetylases and T-cell immune responses

Akimova, T., Beier, U. H., Liu, Y., Wang, L., & Hancock, W. W. (2012) · Blood · doi:10.1182/blood-2011-10-292003 · Cited by 142 · see citing works

The structure of the core NuRD repression complex provides insights into its interaction with chromatin

Millard, C. J., Varma, N., Saleh, A., Morris, K. L., Watson, P. J., Bottrill, A. R., Fairall, L., Smith, C. J., & Schwabe, J. W. R. (2016) · eLife · doi:10.7554/elife.13941 · Cited by 140 · see citing works

Differentiation therapy for the treatment of t(8;21) acute myeloid leukemia using histone deacetylase inhibitors

Bots, M. L., Verbrugge, I., Martin, B. P., Salmon, J. M., Ghisi, M., Baker, A., Stanley, K. L., Shortt, J., Ossenkoppele, G. J., Zuber, J. A., et al. (2014) · Blood · doi:10.1182/blood-2013-03-488114 · Cited by 128 · see citing works

Chemoproteomics and Chemical Probes for Target Discovery

Drewes, G., & Knapp, S. (2018) · Trends in Biotechnology · doi:10.1016/j.tibtech.2018.06.008 · Cited by 132 · see citing works

Histone Deacetylase Inhibitors: Emerging Mechanisms of Resistance

Robey, R. W., Chakraborty, A. R., Basseville, A., Luchenko, V. L., Bahr, J. C., Zhan, Z., & Bates, S. E. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200329f · Cited by 132 · see citing works

Histone Deacetylase Inhibitors Upregulate B Cell microRNAs That Silence AID and Blimp-1 Expression for Epigenetic Modulation of Antibody and Autoantibody Responses

White, C. A., Pone, E. J., Lam, T., Tat, C., Hayama, K. L., Li, G., Zan, H., & Casali, P. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401702 · Cited by 131 · see citing works

Development and Therapeutic Implications of Selective Histone Deacetylase 6 Inhibitors

Kalin, J. H., & Bergman, J. A. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4001659 · Cited by 129 · see citing works

Co-repressor, co-activator and general transcription factor: the many faces of the Sin3 histone deacetylase (HDAC) complex

Adams, G. E., Chandru, A., & Cowley, S. M. (2018) · Biochemical Journal · doi:10.1042/bcj20170314 · Cited by 123 · see citing works

The long non-coding RNA LncHDAC2 drives the self-renewal of liver cancer stem cells via activation of Hedgehog signaling

Wu, J., Zhu, P., Lu, T., Du, Y., Wang, Y., He, L., Ye, B., Liu, B., Yang, L., Wang, J., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.12.015 · Cited by 130 · see citing works

Profiling of Substrates for Zinc‐dependent Lysine Deacylase Enzymes: HDAC3 Exhibits Decrotonylase Activity In Vitro

Madsen, A. S., & Olsen, C. A. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201203754 · Cited by 122 · see citing works

Identification of Histone Deacetylase Inhibitors with Benzoylhydrazide Scaffold that Selectively Inhibit Class I Histone Deacetylases

Wang, Y., Stowe, R. L., Pinello, C. E., Tian, G., Madoux, F., Li, D., Zhao, L. Y., Li, J.-L., Wang, Y., Wang, Y., et al. (2015) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.12.015 · Cited by 122 · see citing works

Chromatin as an expansive canvas for chemical biology

Fierz, B., & Muir, T. W. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.938 · Cited by 121 · see citing works

A dual role for Hdac1: oncosuppressor in tumorigenesis, oncogene in tumor maintenance

Santoro, F., Botrugno, O. A., Zuffo, R. D., Pallavicini, I., Matthews, G. M., Cluse, L. A., Barozzi, I., Senese, S., Fornasari, L., Moretti, S., et al. (2013) · Blood · doi:10.1182/blood-2012-10-461988 · Cited by 120 · see citing works

Primary hepatocyte cultures for pharmaco-toxicological studies: at the busy crossroad of various anti-dedifferentiation strategies

Fraczek, J., Bolleyn, J., Vanhaecke, T., Rogiers, V., & Vinken, M. (2013) · Archives of Toxicology · doi:10.1007/s00204-012-0983-3 · Cited by 119 · see citing works

Structural Basis and SAR for G007-LK, a Lead Stage 1,2,4-Triazole Based Specific Tankyrase 1/2 Inhibitor

Voronkov, A. E., Holsworth, D. D., Waaler, J., Wilson, S. R., Ekblad, B., Perdreau‐Dahl, H., Dinh, H., Drewes, G., Hopf, C., Morth, J. P., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4000566 · Cited by 119 · see citing works

The Commonly Used PI3-Kinase Probe LY294002 Is an Inhibitor of BET Bromodomains

Dittmann, A., Werner, T., Chung, C., Savitski, M. M., Savitski, M. F., Grandi, P., Hopf, C., Lindon, M. J., Neubauer, G., Prinjha, R. K., et al. (2013) · ACS Chemical Biology · doi:10.1021/cb400789e · Cited by 118 · see citing works

Tau interactome mapping based identification of Otub1 as Tau deubiquitinase involved in accumulation of pathological Tau forms in vitro and in vivo

Wang, P., Joberty, G., Buist, A., Vanoosthuyse, A., Stancu, I., Vasconcelos, B., Pierrot, N., Faelth-Savitski, M., Kienlen‐Campard, P., Octave, J., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1663-9 · Cited by 118 · see citing works

HDAC inhibitors as cognitive enhancers in fear, anxiety and trauma therapy: Where do we stand?

Whittle, N., & Singewald, N. (2014) · Biochemical Society Transactions · doi:10.1042/bst20130233 · Cited by 117 · see citing works

Histone deacetylases in monocyte/macrophage development, activation and metabolism: refining HDAC targets for inflammatory and infectious diseases

Gupta, K. D., Shakespear, M. R., Iyer, A., Fairlie, D. P., & Sweet, M. J. (2016) · Clinical & Translational Immunology · doi:10.1038/cti.2015.46 · Cited by 115 · see citing works

Target deconvolution of HDAC pharmacopoeia reveals MBLAC2 as common off-target

Lechner, S., Malgapo, M. I. P., Grätz, C., Steimbach, R. R., Baron, A., Rüther, P. L., Nadal, S., Stumpf, C., Loos, C., Ku, X., et al. (2022) · Nature Chemical Biology · doi:10.1038/s41589-022-01015-5 · Cited by 114 · see citing works

The Ketone Metabolite β-Hydroxybutyrate Attenuates Oxidative Stress in Spinal Cord Injury by Suppression of Class I Histone Deacetylases

Kong, G., Huang, Z., Ji, W., Wang, X., Liu, J., Wu, X., Huang, Z., Li, R., & Zhu, Q. (2017) · Journal of Neurotrauma · doi:10.1089/neu.2017.5192 · Cited by 113 · see citing works

The NSL complex maintains nuclear architecture stability via lamin A/C acetylation

Karoutas, A., Szymanski, W. G., Rausch, T., Guhathakurta, S., Rog‐Zielinska, E. A., Peyronnet, R., Seyfferth, J., Chen, H., de Leeuw, R., Herquel, B., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0397-z · Cited by 113 · see citing works

Ion Mobility Tandem Mass Spectrometry Enhances Performance of Bottom-up Proteomics

Helm, D., Vissers, J. P. C., Hughes, C. J., Hahne, H., Ruprecht, B., Pachl, F., Grzyb, A., Richardson, K., Wildgoose, J. L., Maier, S. K., et al. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m114.041038 · Cited by 108 · see citing works

The MiDAC histone deacetylase complex is essential for embryonic development and has a unique multivalent structure

Turnbull, R. E., Fairall, L., Saleh, A., Kelsall, E., Morris, K. L., Ragan, T. J., Savva, C. G., Chandru, A., Millard, C. J., Makarova, O. V., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17078-8 · Cited by 108 · see citing works

Delayed Fragmentation and Optimized Isolation Width Settings for Improvement of Protein Identification and Accuracy of Isobaric Mass Tag Quantification on Orbitrap-Type Mass Spectrometers

Savitski, M. M., Sweetman, G. M. A., Askenazi, M., Marto, J. A., Lang, M., Zinn, N., & Bantscheff, M. (2011) · Analytical Chemistry · doi:10.1021/ac201760x · Cited by 108 · see citing works

Differential regulation of Bdnf expression in cortical neurons by class-selective histone deacetylase inhibitors

Koppel, I., & Timmusk, T. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.07.015 · Cited by 108 · see citing works

The nucleosome landscape of Plasmodium falciparum reveals chromatin architecture and dynamics of regulatory sequences

Kensche, P. R., Hoeijmakers, W. A. M., Toenhake, C. G., Bras, M., Chappell, L., Berriman, M., & Bártfai, R. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1214 · Cited by 108 · see citing works

Insights into neuroepigenetics through human histone deacetylase PET imaging

Wey, H., Gilbert, T. M., Zürcher, N. R., She, A., Bhanot, A., Taillon, B. D., Schroeder, F. A., Wang, C., Haggarty, S. J., & Hooker, J. M. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf7551 · Cited by 107 · see citing works

HDAC1 and HDAC2 integrate the expression of p53 mutants in pancreatic cancer

Stojanovic, N., Hassan, Z., Wirth, M., Wenzel, P., Beyer, M., Schäfer, C., Brand, P., Kroemer, A., Stauber, R. H., Schmid, R. M., et al. (2016) · Oncogene · doi:10.1038/onc.2016.344 · Cited by 106 · see citing works

Proteomics-Based Methods for Discovery, Quantification, and Validation of Protein–Protein Interactions

Miteva, Y. V., Budayeva, H. G., & Cristea, I. M. (2013) · Analytical Chemistry · doi:10.1021/ac3033257 · Cited by 105 · see citing works

Plants Release Precursors of Histone Deacetylase Inhibitors to Suppress Growth of Competitors

Venturelli, S., Belz, R. G., Kämper, A., Berger, A., von Horn, K., Wegner, A., Böcker, A., Zabulon, G., Langenecker, T., Kohlbacher, O., et al. (2015) · The Plant Cell · doi:10.1105/tpc.15.00585 · Cited by 105 · see citing works

Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors

Cheng, J., Demeulemeester, J., Wedge, D. C., Vollan, H. K. M., Pitt, J. J., Russnes, H. G., Pandey, B. P., Nilsen, G., Nord, S., Bignell, G. R., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01355-0 · Cited by 105 · see citing works

Chemoproteomics Reveals Time-Dependent Binding of Histone Deacetylase Inhibitors to Endogenous Repressor Complexes

Becher, I., Dittmann, A., Savitski, M. M., Hopf, C., Drewes, G., & Bantscheff, M. (2014) · ACS Chemical Biology · doi:10.1021/cb500235n · Cited by 60 · see citing works

Targeting Class I Histone Deacetylases in a “Complex” Environment

Millard, C. J., Watson, P. J., Fairall, L., & Schwabe, J. W. R. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.12.006 · Cited by 180 · see citing works

Chemoproteomics-based target deconvolution and selectivity profiling of Histone Deacetylase inhibitors

Lechner, S., Küster, B., & München, T. U. (2023)

Resolving the deceptive isoform and complex selectivity of HDAC1/2 inhibitors

Payne, N. C., & Mazitschek, R. (2022) · Cell chemical biology · doi:10.1016/j.chembiol.2022.03.002 · Cited by 32 · see citing works

Structure-Based Inhibitor Discovery of Class I Histone Deacetylases (HDACs)

Luo, Y., & Li, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228828 · Cited by 62 · see citing works